Search company, investor...

Founded Year

2019

Stage

Seed VC - II | Alive

Total Raised

$4.65M

Last Raised

$1.9M | 9 mos ago

About Senzo

Senzo develops deep-technology biomedical testing products. It offers COVID-19 test products based on amplified lateral flow (ALF) technology and also integrates with flu testing, tuberculosis, human immunodeficiency virus (HIV), and hepatitis testing. It caters to the clinical testing industry. The company was founded in 2019 and is based in London, United Kingdom.

Headquarters Location

64 Rochester Place

London, England, NW1 9JX,

United Kingdom

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Senzo's Product Videos

Senzo ALF Product Picture.jpg

Senzo's Products & Differentiators

    Amplified Lateral Flow (ALF) products

    Point-of-care lateral flow diagnostics products for home use and professional use

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

Senzo Patents

Senzo has filed 7 patents.

The 3 most popular patent topics include:

  • Analytical chemistry
  • Chromatography
  • Immunologic tests
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/30/2020

1/3/2023

Lighting, Stage lighting, Home automation, Wireless networking, Building automation

Grant

Application Date

9/30/2020

Grant Date

1/3/2023

Title

Related Topics

Lighting, Stage lighting, Home automation, Wireless networking, Building automation

Status

Grant

Latest Senzo News

Senzo Mchunu commends progress made on Sedibeng project, Vaal River system

Aug 30, 2023

Mchunu visited the Vaal region on Tuesday to assess the upgrades and refurbishments undertaken to improve critical bulk pipelines and pump stations in the regional networks. Devdiscourse News Desk | Pretoria | Updated: 30-08-2023 16:40 IST | Created: 30-08-2023 16:40 IST The Minister embarked on a walkabout at about eight construction sites in the Sedibeng region. Image Credit: Twitter(@SAgovnews) Country: SHARE Water and Sanitation Minister, Senzo Mchunu, has expressed optimism about progress made so far on the Sedibeng Sewer Scheme Project and Vaal River System. This as interventions are being made through the Emfuleni Section 63 intervention in the Sedibeng District in Gauteng. Mchunu visited the Vaal region on Tuesday to assess the upgrades and refurbishments undertaken to improve critical bulk pipelines and pump stations in the regional networks. “The upgrades are intended to ensure that wastewater systems function optimally and more importantly to eventually put an end to the protracted pollution at Vaal River and its tributaries,” a Department of Water and Sanitation statement read, adding that Rand Water was the implementing agent. This comes after the Minister invoked and placed Emfuleni Local Municipality under Section 63 of the Water Services Act in 2021 and took over water and sanitation services. The Minister embarked on a walkabout at about eight construction sites in the Sedibeng region. He also made a stop at Sebokeng Wastewater Treatment Works, which is currently being salvaged and upgraded from 100 M/L to a further 50 M/L a day, Leeuwkuil Wastewater Treatment Plant and Rietspruit Wastewater Treatment. The delegation also visited the Rothdene Pump Station, which falls within the Midvaal Local Municipality, and transfers wastewater to Meyerton Wastewater Treatment Works. According to the department, the pump station services Meyerton, Henley on Klip and Rothdene. “Although the issue of vandalism of infrastructure reared its head in almost all the treatment plants visited. Minister Mchunu expressed contentment about the progress made.” Mchunu also inspected several ongoing rehabilitations of pipelines. The department said Mchunu was impressed by Rand Water as an implementing agent and the notable work it has done in addressing sewer spillages and water pollution. “Two weeks ago, we instructed Rand Water as the implementing agent to present a report of progress that they have made in Emfuleni. They gave us a comprehensive presentation showing a lot of progress overall. We are here to monitor, evaluate and verify if indeed there is progress. I can confirm that there is a vast difference between before and now and we are excited about that,” Mchunu said. The department believes that the progress made is making a difference in the residents’ lives. The department said the Minister also made a courtesy visit to Nomali Mhlambi’s house in Vereeniging, whose house floated in the spillage sewer for years before the issue was addressed through the Emfuleni Section 63 intervention. “Mrs Mhlambi expressed her heartfelt gratitude to the Department of Water and Sanitation and Rand Water for coming to her rescue after Emfuleni Local Municipality dismally failed to resolve the matter.” The Minister’s delegation included the Executive Mayor of Emfuleni Local Municipality Sipho Radebe, Rand Water Chairperson Ramateu Monyokolo and Chief Executive Sipho Mosai, officials from Rand Water, the department, Office of the Premier, and the Emfuleni Municipality. READ MORE ON:

Senzo Frequently Asked Questions (FAQ)

  • When was Senzo founded?

    Senzo was founded in 2019.

  • Where is Senzo's headquarters?

    Senzo's headquarters is located at 64 Rochester Place, London.

  • What is Senzo's latest funding round?

    Senzo's latest funding round is Seed VC - II.

  • How much did Senzo raise?

    Senzo raised a total of $4.65M.

  • Who are the investors of Senzo?

    Investors of Senzo include BioAdvance, Wellness Coaches, Biomedical Advanced Research and Development Authority and MedTech Innovator.

  • Who are Senzo's competitors?

    Competitors of Senzo include LumiraDx and 4 more.

  • What products does Senzo offer?

    Senzo's products include Amplified Lateral Flow (ALF) products.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare Senzo to Competitors

i
iAssay

iAssay is a provider of point of care diagnostics solutions. The company provides an open platform for wirelessly connected point of care (POC) diagnostics. The device aggregates test, patient, and wearables data and pushes all data into the cloud. The aim is to eliminate test result delays, delayed diagnosis, sample handling and transportation costs. It also aim to improve patient outcomes and save the healthcare system money.

G
GRIP Molecular

GRIP Molecular develops graphene-based biosensors. It enables lab-quality diagnostics at home. It uses molecular detection technology and dielectrophoresis-enhanced electronics to detect rapid identification of biological threats. The company was founded in 2019 and is based in Saint Paul, Minnesota.

N
NanoSpot.ai

NanoSpot.ai is a diagnostic company that delivers artificial intelligence-based diagnoses to the point of care. It uses a protein system and artificial intelligence to deliver data at the point of care. The company was founded in 2021 and is based in Salt Lake City, Utah.

G
Genz Bio

Genz Bio is a biotechnology company. The company develops screening technology intended to detect breast cancer symptoms using genetic biomarkers. It was founded in 2017 and is based in London, United Kingdom.

Uh-Oh Labs Logo
Uh-Oh Labs

Uh-Oh Labs offers a disease-testing platform. It develops diagnostic and nucleic acid testing that provides precise and lab-grade results for schools, offices, and individuals. The company was founded in 2018 and is based in Santa Clara, California.

E
Efemoral Medical

Efemoral Medical provides medical devices and equipment services. The company develops bioresorbable solutions to treat patients with vascular disease. Its product includes Efemoral Vascular Scaffold System (EVSS). It serves clients in the healthcare sector. Efemoral Medical was founded in 2018 and is based in Los Altos, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.